SCHEMBL3942383

SCHEMBL3942383

CCCc1cccc[n+]1[O-].c1cc2ccc1-2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
KCNH2 Q12809 2/20 0.37
LMNA P02545 2/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MAPT P10636 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
CA2 P00918 5/20 0.35
CA9 Q16790 4/20 0.35
CA1 P00915 3/20 0.35
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
PKM P14618 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SLC2A1 P11166 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
KMT2A Q03164 2/20 0.32
CFTR P13569 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2552339 0.94 ALDH1A1 (0.46) ALDH1A1KCNH2LMNAHTTMAPT
SCHEMBL5234381 0.82 KCNH2 (0.46) ALDH1A1KCNH2LMNAHTTKDM4E
SCHEMBL4928593 0.81 KCNH2 (0.53) ALDH1A1KCNH2LMNAHTTCFTR
SCHEMBL1461158 0.79 KCNH2 (0.56) ALDH1A1KCNH2HTT
SCHEMBL9440072 0.79 KCNH2 (0.56) ALDH1A1KCNH2HTT
SCHEMBL11338813 0.79 KCNH2 (0.56) ALDH1A1KCNH2HTT
SCHEMBL1462481 0.79 KCNH2 (0.56) ALDH1A1KCNH2HTT
SCHEMBL29192036 0.79 KCNH2 (0.56) ALDH1A1KCNH2HTT
SCHEMBL29457179 0.77
SCHEMBL696060 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009095712-A2 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2009-08-06 WO disclosed
WO-2009016410-A2 CHEMICAL COMPOUNDS 831 ASTRAZENECA AB (SE) 2009-02-05 WO disclosed
WO-2008132502-A1 PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-11-06 WO disclosed